[257 Pages Report] According to Future Market Insights (FMI), the global Preterm Birth Diagnostic Test Kits Market was worth US$ 121.3 Mn in 2021 and is expected to grow 1.6X during the forecast period. During the forecast period of 2022-2028, the market is expected to grow at a CAGR of 7.6%, with sales of US $ 203.2 …
Author Archives: Editor AN
Medical Chairs Market to reach a valuation of US$ 13.7 Billion by 2032
[300 Pages Report] As per Future Market Insights, the global medical chairs market is poised to expand at a CAGR of 6.0%, exceeding a valuation of US$ 7.7 Bn in 2022 to US$ 13.7 Bn by 2032. Growth in the medical chairs market is increasing in with rising prevalence of physical ailments combined with advancements in control …
Continue reading “Medical Chairs Market to reach a valuation of US$ 13.7 Billion by 2032”
Autism Spectrum Disorder Management Market Company Profiles, Consumption by Region, Value Chain and Sales Analysis to 2027
Autism spectrum is a neurological disorder. The autism spectrum affects the development and growth of the brain which remain lifelong. The autism spectrum disorder is identified in primary childhood stage. Autism spectrum affects a person in many ways, such as behaviours changes, communication problem in daily lifecycles, lack of interaction in society and many others also. The …
Acoustic Respiration Sensors Market is Booming Worldwide by 2027 | Growth, Share, Demand and Analysis Forecast
Acoustic respiration sensors allows healthcare providers, and clinicians, to continuously access a patient’s breathing.It is technology which is non-invasive and facilitates early detection regarding respiratory distress in patients. For more insights into the market, request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5568 This technology utilizes innovative adhesive sensors with an acoustic transducer and hence continuous monitoring of …
Glucose Sensor Market reaching around US$ 16,382 million by the end of 2032 | FMI
[297 Pages Report] The global glucose sensor market is expected to be worth $7,588 million in 2022. Between 2022 and 2032, global sales of glucose sensors are expected to grow at an 8.6% CAGR, reaching around US$ 16,382 million by the end of 2032. Diabetes mellitus is one of the most widely prevalent endocrine disorder of carbohydrate …
Continue reading “Glucose Sensor Market reaching around US$ 16,382 million by the end of 2032 | FMI”
Healthcare IT Outsourcing Market is projected to grow at a robust CAGR of 7.2% between 2022 and 2032 | FMI
[320 Pages Report] In 2022, the global healthcare IT outsourcing market is expected to be worth $50,025.3 million. In the healthcare industry, outsourcing IT solutions has emerged as an effective way to reduce rising healthcare costs while meeting the growing demand for excellent care. Future Market Insights, in its latest business report, elaborates on the current situation …
Intraoperative Radiation Therapy Systems Market size is projected to be valued at US$ 55.9 Million in 2022
[308 Pages Report] In 2022, the global intraoperative radiation therapy systems market is expected to be worth US$ 55.9 million. The application of therapeutic stages of radiation to the tumour site is known as IORT. IORT is frequently used in the multidisciplinary treatment of privately advanced and recurring disease, alongside outer beam radiation, chemotherapy, and surgery. Intraoperative …
Preclinical Imaging Market expand at a CAGR of 3.5% to reach a valuation of ~US$ 4.7 Bn by the end of the year 2032.
[256 Pages Report] The global preclinical imaging market is expected to be worth US$ 3.3 billion in 2022, and to grow at a CAGR of 3.5% to be worth US$ 4.7 billion by the end of 2032. According to a recent study by Future Market Insights, MRI imaging will lead the global preclinical imaging market with a …
Palliative Care Market is expected to grow at a CAGR of 7.3% between 2022 and 2032
[300 Pages Report] In 2022, the global palliative care market is expected to be worth US$ 13,087.9 million. Palliative care is given to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD), and others, and it includes symptomatic relief for nausea and vomiting, diarrhoea, pain and anxiety, loss …
Vascular Endothelial Growth Factor Inhibitor Market to reach a valuation of ~US$ 33.5 Bn by the year 2032
[422 Pages Report] The global vascular endothelial growth factor inhibitors market is expected to be worth US$ 22.7 billion by the end of 2022, and to grow at a CAGR of 4.0% to be worth US$ 33.5 billion by 2032. According to a recent study by Future Market Insights, biologics are leading the market as drugs, with …